|
Market Cap (24-Jun) $3,159,507 (1,963rd) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 42,322 |
Shortsold (5-Apr) 9,554 (0.01%) (569th) |
|
52w High $0.020 |
52w Low $0.005 |
P/E - |
EPS -0.01 |
ANR released this announcement to the ASX on 13 October 2022, 12:58. The announcement is marked as price sensitive, and is 21 page(s) in length and 2.15MB in size.
You can view all announcements from ANR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ANR was 0.003% short sold according to ASIC data. It was ranked the 598th most shorted stock on the ASX. It is now ranked as the 569th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (05 April 2024).
| Other Recent Announcements from ANR | |
|---|---|
| Anatara Update on GaRP Irritable Bowel Syndrome Trial | 6 June 2023, 8:19 |
| Anatara Investor Presentation | 8 May 2023, 10:44 |
| Registered Office Change | 20 April 2023, 11:51 |
| Anatara Investor Presentation | 13 October 2022, 12:58 |
| Notice of Annual General Meeting/Proxy Form | 10 October 2022, 18:24 |
| R&D Tax Refund Received | 5 October 2022, 10:18 |
| 3FDC Clinical Trial update | 3 October 2022, 8:24 |
You must be logged in to post a reply.
Anatara Lifesciences 